Category: News

How effective are HIV prevention methods?

  Three decades of awareness campaigns have instilled a very clear and consistent message to the public: condoms are the most effective way to prevent an HIV infection. So what happens when a new prevention method emerges – and it is also highly effective? In recent years, multiple studies have confirmed that maintaining an undetectable viral load through the consistent and correct use of antiretroviral treatment (ART) by people living with HIV dramatically reduces the risk of HIV transmission. The reduction is so great that ART can now be offered as a highly effective HIV prevention option.

Read more

IAS 2015: A watershed moment in the HIV response

Vancouver is in the limelight again. This year’s International AIDS Society (IAS) Conference may have marked a watershed moment in our HIV response, with some similarity to the 1996 Vancouver AIDS conference when highly active antiretroviral therapy (HAART) hit the world stage.

Read more

Hepatitis C in Canada

What is hepatitis C? How many people in Canada are affected? With World Hepatitis Day approaching on July 28, service providers have an opportunity to raise awareness about the impact of hepatitis C across Canada. To help you get the message out to the communities you serve, CATIE has produced a series of infographics.

Read more

Let’s talk about sex… ed!

Sex education is rarely without controversy. As a sexual health educator, working with South Asian communities all over Toronto, I see firsthand how sexual misinformation, stigma, cultural and gender norms can all make sex a hard topic to discuss. Lately, however, it seems to be all everyone wants to talk about.

Read more

Déjà vu: Canada’s drug reviewers again mired in bureaucracy

The development of treatment for the cure of hepatitis C (HCV) is moving at a dizzying pace. Indeed, the entire HCV story is one of an unusually fast trajectory, not only the speed of treatment development, but also the spread of the virus. While early cures were injection-based, difficult to tolerate, and boasting a mere 50% success rate after a year of treatment, there now exist cures that involve one pill, once a day, for a regimen that often doesn’t exceed twelve weeks. There are clinical trials being conducted presently to evaluate the efficacy of new treatments at eight and...

Read more